Track-and-trace in Saudi Arabia

Serialization in Saudi Arabia track and trace system

In Saudi Arabia, work has been underway since 2015 to make medicines safer and prevent counterfeiting through serialization. Unlike in Europe (end-to-end), a complete track-and-trace system is to being introduced here.

Designation: Drug Track and Trace System for Pharmaceutical Products (RSD)

Competent authority: Saudi Food and Drug Authority (SFDA)

Products: All medicines for humans and animals

Code type: GS1 Data Matrix

Aggregation: Yes, according to GS1 standards

Timeframe: Start December 2015, serialization from 2017, complete implementation by 2022.

The introduction of a track-and-trace system in Saudi Arabia is part of the Saudi government’s Vision 2030 program. By 2030, Saudi Arabia wants to track all medicines and healthcare products registered for human use, both domestically and internationally.

The GS1 2D Datamatrix code must contain the following information:

  • GTIN
  • Expiration date, format YYMMDD
  • lot/batch number
  • Serial number, variable in length with up to 20 characters, alphanumeric.

SFDA allows different variants of the printed information. In most variants, the expiration date must also be printed on the outer packaging in human-readable form.

Data is used beyond serialization in Saudi Arabia

For pharmaceutical serialization, Saudi Arabia relies on a track-and-trace system that starts with the production or import of the drug and finds its endpoint with the consumer. Each stakeholder, i.e., manufacturer or importer, must register with the SFDA. The entire supply chain is to be monitored this way, to ensure that counterfeit drugs in the supply chain are quickly identified and removed. Also, the data collected from tracking the entire supply chain will provide a basis for further action. In addition to making medicines safer for consumers, availability will also be improved. Other measures include, for example, a real-time stop on recalls, as well as verification of medications by consumers themselves and simplified reporting of adverse reactions.

Third- and pallet-level aggregation

Since October 2019, aggregation of individual packages has been mandatory in Saudi Arabia. An 18-digit Serial Shipping Container Code (SSCC) must be applied at the carton and pallet level. Each whereabouts of an aggregated drug unit will be marked via the GLN.

Initially, only human medicines will be tracked throughout the supply chain. In the future, the measures will be expanded to include herbal and other healthcare products, as well as medicines for animals. Some products are exempt from the track-and-trace process in Saudi Arabia. These include, for example, unsellable samples, medicines for personal use, or those approved for repacking.

Also, similar measures and regulations are planned for the food and medical technology sectors.

More Pharma News